These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10843535)

  • 21. Low dead-space syringes for preventing HIV among people who inject drugs: promise and barriers.
    Zule WA
    Curr Opin HIV AIDS; 2012 Jul; 7(4):369-75. PubMed ID: 22627710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can home-made injectable opiates contribute to the HIV epidemic among injection drug users in the countries of the former Soviet Union?
    Abdala N; Grund JP; Tolstov Y; Kozlov AP; Heimer R
    Addiction; 2006 May; 101(5):731-7. PubMed ID: 16669907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bloody needles: the volumes of blood transferred in simulations of needlestick injuries and shared use of syringes for injection of intravenous drugs.
    Gaughwin MD; Gowans E; Ali R; Burrell C
    AIDS; 1991 Aug; 5(8):1025-7. PubMed ID: 1777162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of Injection-Related Risk Behaviors After Emergency Implementation of a Syringe Services Program During an HIV Outbreak.
    Patel MR; Foote C; Duwve J; Chapman E; Combs B; Fry A; Hall P; Roseberry J; Brooks JT; Broz D
    J Acquir Immune Defic Syndr; 2018 Apr; 77(4):373-382. PubMed ID: 29271829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in the sharing of drug injection equipment among street-recruited injection drug users in Chicago, Illinois, 1994--1996.
    Huo D; Bailey SL; Garfein RS; Ouellet LJ
    Subst Use Misuse; 2005; 40(1):63-76. PubMed ID: 15702649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary laboratory studies of inactivation of HIV-1 in needles and syringes containing infected blood using undiluted household bleach.
    Shapshak P; McCoy CB; Shah SM; Page JB; Rivers JE; Weatherby NL; Chitwood DD; Mash DC
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):754-9. PubMed ID: 8207659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment.
    Thorpe LE; Ouellet LJ; Hershow R; Bailey SL; Williams IT; Williamson J; Monterroso ER; Garfein RS
    Am J Epidemiol; 2002 Apr; 155(7):645-53. PubMed ID: 11914192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Vivo para consumirla y la consumo para vivir" ["I live to inject and inject to live"]: high-risk injection behaviors in Tijuana, Mexico.
    Strathdee SA; Fraga WD; Case P; Firestone M; Brouwer KC; Perez SG; Magis C; Fraga MA
    J Urban Health; 2005 Sep; 82(3 Suppl 4):iv58-73. PubMed ID: 16107441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sharing of drug preparation equipment as a risk factor for hepatitis C.
    Hagan H; Thiede H; Weiss NS; Hopkins SG; Duchin JS; Alexander ER
    Am J Public Health; 2001 Jan; 91(1):42-6. PubMed ID: 11189822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viability of HIV-1 in syringes: implications for interventions among injection drug users.
    Heimer R; Abdala N
    AIDS Read; 2000 Jul; 10(7):410-7. PubMed ID: 10932845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk.
    Kasper KJ; Manoharan I; Hallam B; Coleman CE; Koivu SL; Weir MA; McCormick JK; Silverman MS
    PLoS One; 2019; 14(8):e0219777. PubMed ID: 31398210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for HIV infection among drug users in Yunnan province, China: association with intravenous drug use and protective effect of boiling reusable needles and syringes.
    Xia M; Kreiss JK; Holmes KK
    AIDS; 1994 Dec; 8(12):1701-6. PubMed ID: 7888119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Syringe cleaning techniques and transmission of HIV.
    Druce JD; Locarnini SA; Birch CJ
    AIDS; 1995 Sep; 9(9):1105-7. PubMed ID: 8527090
    [No Abstract]   [Full Text] [Related]  

  • 34. HIV, drug-use paraphernalia, and bleach.
    Haverkos HW; Jones TS
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):741-2. PubMed ID: 8207656
    [No Abstract]   [Full Text] [Related]  

  • 35. Detection of infectious human immunodeficiency type 1 virus in discarded syringes of intravenous drug users.
    Zamora AB; Rivera MO; García-Algar O; Caylà Buqueras J; Vall Combelles O; García-Sáiz A
    Pediatr Infect Dis J; 1998 Jul; 17(7):655-7. PubMed ID: 9686738
    [No Abstract]   [Full Text] [Related]  

  • 36. Arrests and incarceration of injection drug users for syringe possession in Massachusetts: implications for HIV prevention.
    Case P; Meehan T; Jones TS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S71-5. PubMed ID: 9663627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risk behaviors for HIV transmission among the recent clients of a syringe-exchange program in Madrid, 1993].
    Bravo Portela MJ; Barrio Anta G; de la Fuente de Hoz L; Colomo Gómez C; Royuela Morales L; Estébanez Estébanez P
    Gac Sanit; 1996; 10(57):261-73. PubMed ID: 9072510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oregon's exclusion of syringes from its 1987 drug paraphernalia law was an HIV prevention measure.
    Wright LN; Gebbie KM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S144-5. PubMed ID: 9663641
    [No Abstract]   [Full Text] [Related]  

  • 39. Inactivation of HCV and HIV by microwave: a novel approach for prevention of virus transmission among people who inject drugs.
    Siddharta A; Pfaender S; Malassa A; Doerrbecker J; Anggakusuma ; Engelmann M; Nugraha B; Steinmann J; Todt D; Vondran FW; Mateu-Gelabert P; Goffinet C; Steinmann E
    Sci Rep; 2016 Nov; 6():36619. PubMed ID: 27857152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.